a-Patchoulene
Compound with spectra: 6 MS (GC)
| SpectraBase Compound ID | 4DkJpP3xoRW |
|---|---|
| InChI | InChI=1S/C15H24/c1-10-7-8-15-11(2)5-6-12(9-13(10)15)14(15,3)4/h5,10,12-13H,6-9H2,1-4H3/t10?,12-,13?,15+/m1/s1 |
| InChIKey | KVQOADNSNSUAJT-IONBAEIFSA-N |
| Mol Weight | 204.36 g/mol |
| Molecular Formula | C15H24 |
| Exact Mass | 204.187801 g/mol |
| Enantiomer InChIKey | KVQOADNSNSUAJT-FTSVBKQBSA-N |
| Copyright | Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
|---|---|
| Source of Spectrum | DigiLab GmbH (C) 2024 |
| Technique | GC/MS |
| Copyright | Database Compilation Copyright © 2023-2024 John Wiley and Sons, Inc. Copyright © 2023-2024 John Wiley and Sons, Inc., Portions Copyright Wiley-VCH GmbH, Adams Library under license from Diablo Analytical. All Rights Reserved. |
|---|---|
| Source of Sample | SAFC Cat.no. W283800 |
| Source of Spectrum | Prof. L. Mondello (Chromaleont s.r.l./Univ. Messina, Italy) |
| Copyright | Copyright © 2020-2024 John Wiley & Sons, Inc. All Rights Reserved. |
|---|---|
| Source of Spectrum | A-0-0-168 |
| Copyright | Copyright © 2020-2024 John Wiley & Sons, Inc. All Rights Reserved. |
|---|---|
| Source of Spectrum | LQ-1992-4179-0 |
| Copyright | Copyright © 2020-2024 John Wiley & Sons, Inc. All Rights Reserved. |
|---|---|
| Source of Spectrum | TA-0-1097-3 |
| Copyright | Copyright © 2020-2024 John Wiley & Sons, Inc. All Rights Reserved. |
|---|---|
| Source of Spectrum | UT-1990-1465-0 |
- Patchoulene <alpha->
- 1H-3a,7-Methanoazulene,2,3,6,7,8,8a-hexahydro-1,4,9,9-tetramethyl-,(1alpha,3aalpha,7alpha,8abeta)
- 1H-3a,7-Methanoazulene, 2,3,6,7,8,8a-hexahydro-1,4,9,9-tetramethyl-, (1alpha,3a.alpha,7alpha,8a.beta)-
Bicyclo[3.3.1]non-2-ene-9-methanol, 1,2,6-trimethyl-9-propyl-, (endo,anti)-(.+-.)-
1,2-Dioxane-3-acetic acid, 6-[2-(1,4,4a,7,8,8a-hexahydro-1,1,3,6-tetramethyl-2-naphthalenyl)ethyl]-.alpha.,6-dimethyl-, methyl ester, [3R-[3.alpha.(R*),6.alpha.(4aR*,8aS*)]]-
(20R,22E)-2-Methylene-25-(4-methylpentanoyl)-24-oxo-26,27-cyclo-22-dehydro-1.alpha.-hydroxy-19-norvitamin D3
(3Ab, 5aa,6a,8aa)-4,5,6,6a,7,8-hexahydro-3a,6-dimethyl-cyclopenta(C)pentalen-3(1ah)-one
LANSIC_ACID_3-ETHYLESTER
4-BETA-METHOXY,4A-ALPHA-METHYL-1,4,4A,8,8A-BETA,9,10,10A-ALPHA-OCTAHYDRO-6(7H)-PHENANTHRENONE
3-Cyclohexene-1-propanoic acid, 1,3-dimethyl-6-(1-methylethenyl)-2-[3-methyl-5-[[4-O-(3-methyl-1-oxo-2-butenyl)-.alpha.-L-arabinopyranosyl]oxy]pentyl]-, methyl ester, [1S-[1.alpha.,2.beta.(R*),6.beta.]]-
(3Ab, 5aa,6a,8aa)-4,5,6,6a,7,8-hexahydro-3a,6-dimethyl-cyclopenta(C)pentalen-1(3ah)-one
(1R,7S)-1,3,10,10-Tetramethyltricyclo[5.2.1.0(2,6)]deca-2,5-diene
This compound is available in the following databases:
Mass Spectra of Designer Drugs 2024
Author: Peter Rösner
This library enables fast and reliable identification of the latest illegal designer drugs. It is updated annually. Learn more.